SPY399.24-2.48 -0.62%
DIA321.11-1.12 -0.35%
IXIC11,670.48-134.52 -1.14%

BRIEF-Aileron Therapeutics - On April 25, 2022, Richard J. Wanstall, CFO, Notified Company Of His Resignation, Effective May 6, 2022

reuters.com · 04/29/2022 17:57
BRIEF-Aileron Therapeutics - On April 25, 2022, Richard J. Wanstall, CFO, Notified Company Of His Resignation, Effective May 6, 2022

- Aileron Therapeutics Inc ALRN:

  • AILERON THERAPEUTICS - ON APRIL 25, 2022, RICHARD J. WANSTALL, CFO, NOTIFIED COMPANY OF HIS RESIGNATION, EFFECTIVE MAY 6, 2022

  • AILERON THERAPEUTICS INC - HAS INITIATED A SEARCH PROCESS FOR POSITION OF CHIEF FINANCIAL OFFICER OF COMPANY

Further company coverage: ALRN


((Reuters.Briefs@thomsonreuters.com;))